Over the past two decades, developments in regenerative medicine in gastroenterology have been greatly enhanced by the application of stem cells, which can self-replicate and differentiate into any somatic cell. The discovery of induced pluripotent stem cells has opened remarkable perspectives on tissue re-generation, including their use as a bridge to transplantation or as supportive therapy in patients with organ failure. The improvements in DNA manipulation and gene editing strategies have also allowed to clarify the physiopathology and to correct the phenotype of several monogenic diseases, both in vivo and in vitro. Further progress has been made with the development of three-dimensional cultures, known as organoids, which have demonstrated morphological and functional complexity comparable to that of a miniature organ. Hence, owing to its protean applications and potential benefits, cell and organoid transplantation has become a hot topic for the management of gastrointestinal diseases. In this review, we describe current knowledge on cell therapies in hepatology and pancreatology, providing insight into their future applications in regenerative medicine.(c) 2022 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.

Giuli, L., Santopaolo, F., Pallozzi, M., Pellegrino, A. A., Coppola, G., Gasbarrini, A., Ponziani, F. R., Cellular therapies in liver and pancreatic diseases, <<DIGESTIVE AND LIVER DISEASE>>, N/A; 55 (5): 563-579. [doi:10.1016/j.dld.2022.11.013] [https://hdl.handle.net/10807/241372]

Cellular therapies in liver and pancreatic diseases

Giuli, Lucia;Santopaolo, Francesco;Pallozzi, Maria;Pellegrino, Antonio Agostino;Coppola, Gaetano;Gasbarrini, Antonio;Ponziani, Francesca Romana
2023

Abstract

Over the past two decades, developments in regenerative medicine in gastroenterology have been greatly enhanced by the application of stem cells, which can self-replicate and differentiate into any somatic cell. The discovery of induced pluripotent stem cells has opened remarkable perspectives on tissue re-generation, including their use as a bridge to transplantation or as supportive therapy in patients with organ failure. The improvements in DNA manipulation and gene editing strategies have also allowed to clarify the physiopathology and to correct the phenotype of several monogenic diseases, both in vivo and in vitro. Further progress has been made with the development of three-dimensional cultures, known as organoids, which have demonstrated morphological and functional complexity comparable to that of a miniature organ. Hence, owing to its protean applications and potential benefits, cell and organoid transplantation has become a hot topic for the management of gastrointestinal diseases. In this review, we describe current knowledge on cell therapies in hepatology and pancreatology, providing insight into their future applications in regenerative medicine.(c) 2022 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
2023
Inglese
Giuli, L., Santopaolo, F., Pallozzi, M., Pellegrino, A. A., Coppola, G., Gasbarrini, A., Ponziani, F. R., Cellular therapies in liver and pancreatic diseases, <<DIGESTIVE AND LIVER DISEASE>>, N/A; 55 (5): 563-579. [doi:10.1016/j.dld.2022.11.013] [https://hdl.handle.net/10807/241372]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/241372
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact